3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
2
Drug-Related Side Effects and Adverse Reactions
2
Central Nervous System Neoplasms
2
Thrombocytopenia
1
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neoplasms
1
Medulloblastoma
1
Lymphoma
1
Liposarcoma
1
Intraocular Lymphoma
1
Familial ependymoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Astrocytoma
1
Interventions
Trabectedin
2
Doxorubicin
2
sodium thiosulfate
1
plitidepsin
1
milademetan
1
avelumab
1
atezolizumab
1
X-Rays
1
TTI-621
1
Specimen Handling
1
Reverse Transcriptase Polymerase Chain Reaction
1
Platinum
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Immunoenzyme Techniques
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gene Expression Profiling
1
Cytoreduction Surgical Procedures
1
Cyproheptadine
1
Cisplatin
1
Blotting, Western
1
Biopsy
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Liposarcoma
×
sodium thiosulfate
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled